Table 3. Cytokines/chemokines/adipokines in the supernatant of ASCs.

ASC-secreted factors	visceral	subcutaneous	ASC-secreted factors	visceral	subcutaneous
CCL2	0.91 ± 1.02	0.56 ± 0.52	IL-2	0.02 ± 0.03	0.03 ± 0.05
TNF-α	0.19 ± 0.15	0.38 ± 0.38	CCL8	0.03 ± 0.04	0.16 ± 0.23
IL-3	0.20 ± 0.08	0.29 ± 0.17	IL-4	0.01 ± 0.02	0.02 ± 0.03
TNF-β	0.13 ± 0.04	0.24 ± 0.19	CCL7	0.01 ± 0.02	0.04 ± 0.05
CXCL5	0.48 ± 0.37	0.08 ± 0.12	EGF	0.09 ± 0.04	0.17 ± 0.14
IL-6	3.99 ± 0.43	1.94 ± 0.49	IL-5	0.01 ± 0.02	0.16 ± 0.11
angiogenin	0.68 ± 0.03	0.68 ± 0.09	IGF-I	0.03 ± 0.05	0.02 ± 0.03
IL-7	0.33 ± 0.31	0.22 ± 0.10	CCL22	0.06 ± 0.08	0.07 ± 0.09
oncostatin M	0.31 ± 0.06	0.35 ± 0.10	CSF1	0.22 ± 0.13	0.04 ± 0.05
IL-8	2.85 ± 0.52	1.52 ± 0.14	CXCL9	0.02 ± 0.03	0.02 ± 0.03
GRO	3.27 ± 0.81	1.80 ± 0.37	GM-CSF	0.03 ± 0.05	0.06 ± 0.08
IL-10	0.68 ± 0.52	0.48 ± 0.24	CCL15	0.03 ± 0.05	0.20 ± 0.14
CCL5	0.49 ± 0.16	0.45 ± 0.09	thrombopoietin	0.02 ± 0.02	0.03 ± 0.04
GRO-α	0.38 ± 0.35	0.06 ± 0.08	VEGF	0.02 ± 0.03	0.03 ± 0.05
SDF-1	0.13 ± 0.07	0.12 ± 0.04	IL-12	0.03 ± 0.04	0.03 ± 0.05
IL-1α	0.12 ± 0.06	0.59 ± 0.69	SCF	0.03 ± 0.04	0.04 ± 0.06
CCL17	0.14 ± 0.04	0.26 ± 0.21	PDGFB	0.02 ± 0.03	0.02 ± 0.03
IL-1β	0.13 ± 0.08	0.56 ± 0.68	CCL1	0.01 ± 0.02	0.02 ± 0.03
INF-γ	0.12 ± 0.12	0.30 ± 0.34	IL-13	0.01 ± 0.02	0.02 ± 0.03
TGF-β1	0.12 ± 0.08	0.21 ± 0.19	leptin	0.04 ± 0.05	0.03 ± 0.05
IL-15	0.02 ± 0.02	0.02 ± 0.03

Relative chemokine secretion ratio of ASCs. The signal of the positive control was assigned as 1.

Abbreviations: CCL, C-C motif chemokine; TNF, tumor necrosis factor; IL, interleukin; CXCL, C-X-C motif chemokine; GRO, growth-regulated protein; SDF, stromal cell-derived factor 1; TGF, transforming growth factor; EGF, epidermal growth factor; IGF, insulin-like growth factor; CSF, colony-stimulating factor; GM-CSF, granulocyte-macrophage colony-stimulating factor; VEGF, vascular endothelial growth factor; SCF, stem cell factor; PDGF, platelet-derived growth factor.